Cite
MLA Citation
Prakash K. Bhuyan et al.. “Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.” Human vaccines & immunotherapeutics, vol. 17, no. 5, 2021, pp. 1288–1293. http://access.bl.uk/ark:/81055/vdc_100127475149.0x00000a